121
Participants
Start Date
May 31, 2012
Primary Completion Date
June 30, 2013
Study Completion Date
June 30, 2013
AMG 747
Three dose levels once-daily oral administration
Placebo
Once-daily oral administration
Research Site, Takapuna, Auckland
Research Site, Melbourne
Research Site, Glenside
Research Site, Mount Claremont
Research Site, Glen Oaks
Research Site, Rochester
Research Site, Washington D.C.
Research Site, Raleigh
Research Site, Madrid
Research Site, Atlanta
Research Site, North Miami
Research Site, Santander
Research Site, Dayton
Research Site, Valencia
Research Site, Chicago
Research Site, Houston
Research Site, Los Angeles
Research Site, Culver City
Research Site, Torrance
Research Site, Norwalk
Research Site, Cerritos
Research Site, San Bernardino
Research Site, Anaheim
Research Site, Garden Grove
Research Site, Moscow
Research Site, Moscow
Research Site, Khot'kovo
Research Site, Saint Petersburg
Research Site, Saratov
Research Site, Singapore
Research Site, Marlton
Research Site, Calgary
Research Site, Penticton
Research Site, Kingston
Research Site, Montreal
Research Site, Barcelona
Research Site, Cornellà de Llobregat
Research Site, L'Hospitalet de Llobregat
Lead Sponsor
Amgen
INDUSTRY